Surgical Heart Valve Replacement Portfolio

Trifecta™ Valve with Glide™ Technology designed for conventional and minimally-invasive procedures

Portfolio Overview

  • Innovative heart valve solutions
  • Designed for exceptional hemodynamics and durability
  • Technology that gives you more control for precise placement

Exceptional Hemodynamics

St. Jude Medical™ surgical valves are designed to provide exceptional hemodynamics by mimicking the function of a healthy heart valve. 

Trifecta celebrates 10 year anniversary and Trifecta GT celebrates 1 year anniversary

Trifecta™ Family of Valves: Time Tested and Clinically Proven

2017 is a milestone year for the Trifecta™ family of valves, marking the ten-year anniversary of the Trifecta™ valve, with the Trifecta™ valve with Glide™ Technology celebrating one year of commercial availability.

Building upon the industry-leading heart-valve technology of the Trifecta™ valve, the Trifecta™ valve with Glide™ Technology combines ease of implantation, exceptional hemodynamic performance and excellent durability. Discover the clinical evidence behind our valve success.

Request Information

Celebrating Four Decades of Valve Innovation

As pioneers in heart valve technology, St. Jude Medical is an experienced mechanical valve company in the world with more than two million mechanical valves implanted worldwide to date. We offer catheter-based and surgical solutions—including market-leading mechanical and tissue stented heart valves designed for exceptional hemodynamics, durability and ease of implantation.

It’s part of the excitement of medicine to me. It’s bringing something new to the field.
—Dr. Robert Emery, Cardiovascular and Thoracic Surgeon


Watch this video to learn more about our innovations in heart valve technology.

Proven Exceptional Hemodynamics1

At St. Jude Medical, we design and carry out comprehensive, robust and globally relevant studies to establish the safety, efficacy and cost-effectiveness of our transformative therapies. Watch this video to see highlights of results from a global, multicenter, prospective clinical study.

This study establishes the safety and early clinical and hemodynamic performance of the Trifecta™ valve in one of the largest prospective evaluations ever performed.1

See evidence,

Transforming the Treatment of Structural Heart Disease

Many adults worldwide battle conditions such as valvular disease and aortic stenosis, the narrowing of the aortic valve. In fact, aortic stenosis is the world’s most common noncongenital valve disease.2 St. Jude Medical offers surgical and transcatheter options for treating these diseases. We are focused on improving the lives of patients and offering physicians like you products designed for ease of use and that have proven clinical outcomes.1,3

Learn more about our approach to structural heart disease.

Drawing of the heart that shows areas affected by structural heart defects

1. Bavaria, J. E., Desai, N. D., Cheung, A., Petracek, M. R., Groh, M. A., Borger, M. A., & Schaff, H. V. (2014). The St. Jude Medical Trifecta aortic pericardial valve: Results from the global, multicenter, prospective clinical study. The Journal of Thoracic and Cardiovascular Surgery, 147(2), 590-597.
2. Welt, F. G. P., Davidson, M. J., Leon, M. B., & Eisenhauer, A. C. (2011). Transcatheter aortic valve replacement. Circulation, 124, 2944-2948.
3. Forbes, T. (2011, July). Interim results of the Amplatzer septal occluder post approval study. Presented at the meeting of the Pediatric and Adult Interventional Cardiac Symposium, Boston, MA.

Orange 24 surrounded by headset, represents "Place an order"

Contact Customer Service

Our customer service experts can help with your product orders or questions.